Approval · Notice of Compliance 5057 · 1995
LOZIDE: Notice of Compliance 5057
Issued August 16, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5057
- Date
- August 16, 1995
- Company
- Servier Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 1.25mg tab
- Therapeutic class
- Diuretic, antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOZIDE | 02179709 | Cancelled Post Market |
Medicinal ingredients
- INDAPAMIDE 1.25 MG per TAB